Zimmer Biomet

Zimmer BiometZimmer Biomet
ZB

Zimmer Biomet

Global medical technology leader providing orthopedic reconstructive products, surgical robotics, and digital health solutions.

DR 751927Active18000Warsaw, United States
Rate

About

Zimmer Biomet is a global leader in orthopedic care, offering a comprehensive portfolio of products and technologies including implants, robotics, and digital solutions. They serve healthcare professionals and patients with innovations in areas such as knee, hip, shoulder, and sports medicine. The company is committed to advancing patient outcomes through integrated platforms like ZBEdge® Analytics and ROSA® Robotics.
Frequently asked

What does Zimmer Biomet do?

Zimmer Biomet is a global leader in orthopedic care, offering a comprehensive portfolio of products and technologies including implants, robotics, and digital solutions. They serve healthcare professionals and patients with innovations in areas such as knee, hip, shoulder, and sports medicine. The company is committed to advancing patient outcomes through integrated platforms like ZBEdge® Analytics and ROSA® Robotics.

What is Zimmer Biomet's revenue?

StartupHub estimates Zimmer Biomet's annual revenue at $5.1B (range $3.0B to $9.0B, 62% confidence), based on comparable companies in the sector.

What is Zimmer Biomet's valuation?

StartupHub estimates Zimmer Biomet's effective valuation at $6.3B (range $4.5B to $10.8B, 22% confidence), based on comparable companies in the sector.

How much funding has Zimmer Biomet raised?

Zimmer Biomet has raised a total of $1.8B in funding.

Where is Zimmer Biomet headquartered?

Zimmer Biomet is headquartered in Warsaw, Indiana, United States.

When was Zimmer Biomet founded?

Zimmer Biomet was founded in 1927.

What industry does Zimmer Biomet operate in?

Zimmer Biomet operates in MedTech, Healthcare, AI.

How many employees does Zimmer Biomet have?

Zimmer Biomet has approximately 18000 people on record.

HEADCOUNT
18000
DOMAIN RATING
75
Comments

No comments yet. Be the first to share your take.